Redhill生物製藥 RDHL 深 滬
已收盤 09-06 16:00:00 美东时间
9.38
+0.430
+4.80%
華盛通- 最 高9.60
- 今 開9.05
- 成交量 6.90万股
- 最 低 8.99
- 昨 收 8.95
- 總市值 1201.15万
- 52周最高 82.00
- 市盈率 靜 0.10
- 換手率 5.39%
- 52周最低 6.425
- 委 比 -77.78%
- 總股本 128.05万
- 歷史最高 22220.00
- 量 比 1.21
- 振 幅 6.82%
- 歷史最低 7.07
- 每 手 1
- 風險率 9.39%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多RedHill Biopharma Achieves Nasdaq Compliance
RedHill Biopharma (RDHL) has released an update. RedHill Biopharma Ltd. has ann...
09-05 20:22
RedHill Biopharma regains compliance with Nasdaq
RedHill Biopharma (NASDAQ:RDHL) said it has received confirmation from the Nasdaq, stating that the company has regained compliance with the minimum bid price requirement. Press Release More on RedHil...
09-05 19:18
RedHill Reports Opaganib Reduces COVID-19 Deaths
RedHill Biopharma (RDHL) has released an update. RedHill Biopharma Ltd. has rep...
09-03 19:27
RedHill Biopharma Streamlines for Growth in H1 2024
RedHill Biopharma (RDHL) has released an update. RedHill Biopharma has reported...
08-30 02:45
RedHill’s Opaganib Drug Wins FDA Orphan Status
RedHill Biopharma (RDHL) has released an update. RedHill Biopharma Ltd. has ann...
08-26 19:27
RedHill Biopharma Launches Talicia in UAE
RedHill Biopharma (RDHL) has released an update. RedHill Biopharma Ltd. has ann...
08-21 19:27
Talicia® Launched in the United Arab Emirates
RedHill's Talicia, the first approved low-dose rifabutin-containing all-in-one combination treatment for H. pylori, is now available on prescription to treat adults with H. pylori infection ...
08-21 19:00
美股异动 | Redhill(RDHL.US)大涨18% opaganib有望用于肥胖相关疾病
Redhill Biopharma(RDHL.US)公布了多项体内研究的积极结果。
08-19 21:31
Israel-Based RedHill's Investigational COVID-19 Treatment Shows Encouraging Action In Obesity And Diabetes
RedHill Biopharma released study results showing opaganib's potential in treating Type 2 diabetes and obesity. The drug's ability to target sphingolipid metabolism could help prevent weight gain and improve glucose tolerance.
08-19 20:56
RedHill Biopharma plans to implement ADS ratio change
RedHill Biopharma (NASDAQ:RDHL) plans to implement a ratio change of the Co.'s ADSs to its non-traded ordinary shares from the current ratio of 1 ADS representing 400 ordinary shares to a new ratio of...
08-16 22:23
